CHARLOTTE, NC – After partnering with FCB Health – a leading pharmaceutical marketing and advertising agency – in 2016 on developing a Brand name for AbbVie’s new hepatitis C treatment, the delivered Brand name MAVYRETTM has now received FDA approval.
For this particular project, brandsymbol coordinated the creative efforts with FCB Health and played an integral role in assessing hundreds of AbbVie’s name candidates through vigorous legal and trademark screening, linguistics testing, and in-depth safety and regulatory research. After compiling and analyzing the resulting data, brandsymbol along with SafeMark Regulatory Consulting – the safety and regulatory subsidiary of brandsymbol – developed the required safety documents for AbbVie to effectively and efficiently submit MAVYRETTM for approval.
According to AbbVie’s press release, “MAVYRETTM is an 8-week, pan-genotypic option for patients without cirrhosis and who are new to treatment, who comprise the majority of people living with [Hepatitis C Virus] (HCV).” The World Health Organization (WHO) indicates that there are 71 million people in the world living with HCV, with up to 95% of those patients being eligible to receive MAVYRETTM.
This approval marks the first of many for brandsymbol’s progressing client-relationship with AbbVie, and the first as a partner with FCB Health. Brandsymbol looks forward to cultivating its relationship with FCB Health and other pharmaceutical advertising agencies around the world to combine expertise and offer pharmaceutical clients an all-around, world-class Brand.
With over two decades of experience, brandsymbol was founded with the goal of revitalizing the agency-client relationship by innovating and transforming the branding process, to deliver world-class solutions, customized for each client. Our proprietary i4 Methodology is engineered to provide senior-level expertise, global creative, advanced legal & regulatory solutions to deliver clients world-class brands that are based on facts and figures, not opinions and observations.
For More Information: